Back to Journals » Journal of Blood Medicine » Volume 1

Solitary plasmacytoma of the jaw

Authors Marotta S, Di Micco P

Published 30 March 2010 Volume 2010:1 Pages 33—36

DOI https://doi.org/10.2147/JBM.S8385

Review by Single anonymous peer review

Peer reviewer comments 2



Serena Marotta1, Pierpaolo Di Micco2

1Haematology Division, Second University of Naples, Italy; 2Internal Medicina, Fatebenefratelli Hospital of Naples, Italy

Abstract: Solitary plasmacytoma may be considered as a rare neoplasm of head and neck and is a different disease compared to multiple myeloma. The main difference is related to the better clinical prognosis of solitary plasmacytoma, which may be clinically silent for several years but several local recurrences may be possible once diagnosed and treated. Clinical signs and symptoms of solitary plasmacytoma are related to bone pain and possible bone fractures. Partial local impairment of local bone function may be present. Bone swelling and local involvement of mucosa and local soft tissue may be revealed. Systemic findings related to the production of monoclonal protein are usually not present and a monoclonal spike in serum electrophoresis may be absent as the monoclonal Bence–Jones protein in the urine. Other systemic dysfunctions as systemic bone marrow involvement with related anemia and absent thrombocytopenia. However, although very rare, solitary plasmacytoma of the jaw may have several clinical presentations and here we review clinical differences reported in the literature.

Keywords: solitary plasmacytoma, multiple myeloma, monoclonal, bone function, fracture

Creative Commons License © 2010 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.